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I
n Science & Practice Perspectives, researchers and serv-
ice providers present and respond to each other’s
ideas and insights on important practical topics per-
taining to drug abuse. All share the goal of improving
treatment and prevention and the conviction that dia-
logue and collaboration among professional groups are
essential for success.
This issue of Perspectives covers topics ranging from
one of the first and still the most common of drug abuse
interventions—12-step recovery programs, to one of
the most innovative—antinicotine treatment with manda-
tory abstinence in a substance abuse treatment setting.
Our five articles and our roundtable responses contain
well-grounded recommendations ranging from best clin-
ical practices to the need for system-wide adaptation and
integration. 
•  Greg Brigham draws attention to commonalities in the
ways 12-step programs and science-based drug abuse
treatments promote recovery. He submits that more
research attention to 12-step programs can deepen our
understanding of these processes in ways that strengthen
both types of interventions. Researcher-respondents
Robert Forman, Keith Humphreys, and Scott Tonigan
summarize the empirical evidence on preparing patients
in drug abuse therapy for successful engagement in 12-
step programs after they leave treatment.
•  Lawyer and drug abuse researcher Douglas Marlowe
urges closer integration of the criminal justice and drug
abuse treatment systems. He cites evidence that for
drug-involved offenders in treatment after incarcera-
tion, a combined criminal justice-drug abuse assess-
ment can determine the best division of labor between
criminal justice supervisors and drug treatment coun-
selors. In response, Allan Cohen, Jennifer Mankey, and
William Wendt describe aspects of the public safety-
public health interfaces in their own communities
and their efforts to increase coordination through cross-
training, blended funding, and other means.
•  Paula Riggs reviews what researchers have learned about
treating adolescents for substance use and comorbid
psychiatric disorders and concludes that while many
key issues require further investigation, current data
are enough to guide a basic set of best treatment prac-
tices. Building on her review and original research,
Dr. Riggs makes a strong case against the common prac-
tice of withholding psychiatric treatment for youthful
patients until they have achieved a period of sustained
abstinence. Respondents Patricia Chandler, Franklin
Ingram, and Joseph Richard highlight the specific best
practice recommendations they intend to incorporate
in their own clinical work. 
•  James Sharp and coauthors describe how they incorpo-
rated antinicotine treatment with zero tolerance for
tobacco possession or use into three State-funded res-
idential addiction treatment centers. Researchers Lirio
Covey, Anne Joseph, and Steven Shoptaw praise the
authors’ “groundbreaking” initiative and agree that the
rationale is strong for treating nicotine addiction no dif-
ferently from the other addictions. However, they also
judge that data are needed to answer many questions
concerning which clinical antinicotine policies and inter-
ventions can yield the best overall benefits for patients
during and after treatment for other addictions.  
• Nancy Petry and Michael Bohn relate their experiences
using low-cost incentives that reinforce drug abuse
patients’ motivation to succeed in treatment. Dr. Petry
describes what she has learned from her formal research
on the practice, and Dr. Bohn tells about implementing
affordable incentives in his community-based clinic.
As we would expect from practitioners of two profes-
sions oriented toward a single great goal, our article authors
and respondents widely concur. Not surprisingly, however,
given researchers’ and clinicians’ different training and
roles, their views occasionally diverge. Airing and exam-
ining such differences is an indispensable and creative
part of effective collaboration. The Perspectives peer review
process ensures that the information and interpretations
presented here are of high quality, even when consensus
has yet to emerge.
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